Literature DB >> 23731542

Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.

John A Martignetti1, Lifeng Tian, Dong Li, Maria Celeste M Ramirez, Olga Camacho-Vanegas, Sandra Catalina Camacho, Yiran Guo, Dina J Zand, Audrey M Bernstein, Sandra K Masur, Cecilia E Kim, Frederick G Otieno, Cuiping Hou, Nada Abdel-Magid, Ben Tweddale, Denise Metry, Jean-Christophe Fournet, Eniko Papp, Elizabeth W McPherson, Carrie Zabel, Guy Vaksmann, Cyril Morisot, Brendan Keating, Patrick M Sleiman, Jeffrey A Cleveland, David B Everman, Elaine Zackai, Hakon Hakonarson.   

Abstract

Infantile myofibromatosis (IM) is a disorder of mesenchymal proliferation characterized by the development of nonmetastasizing tumors in the skin, muscle, bone, and viscera. Occurrence within families across multiple generations is suggestive of an autosomal-dominant (AD) inheritance pattern, but autosomal-recessive (AR) modes of inheritance have also been proposed. We performed whole-exome sequencing (WES) in members of nine unrelated families clinically diagnosed with AD IM to identify the genetic origin of the disorder. In eight of the families, we identified one of two disease-causing mutations, c.1978C>A (p.Pro660Thr) and c.1681C>T (p.Arg561Cys), in PDGFRB. Intriguingly, one family did not have either of these PDGFRB mutations but all affected individuals had a c.4556T>C (p.Leu1519Pro) mutation in NOTCH3. Our studies suggest that mutations in PDGFRB are a cause of IM and highlight NOTCH3 as a candidate gene. Further studies of the crosstalk between PDGFRB and NOTCH pathways may offer new opportunities to identify mutations in other genes that result in IM and is a necessary first step toward understanding the mechanisms of both tumor growth and regression and its targeted treatment.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23731542      PMCID: PMC3675260          DOI: 10.1016/j.ajhg.2013.04.024

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  FIBROUS HAMARTOMA OF INFANCY.

Authors:  F M ENZINGER
Journal:  Cancer       Date:  1965-02       Impact factor: 6.860

2.  CONGENITAL MESENCHYMAL TUMORS.

Authors:  S L KAUFFMAN; A P STOUT
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

Review 3.  Autosomal dominant inheritance of infantile myofibromatosis.

Authors:  Dina J Zand; Dale Huff; David Everman; Karen Russell; Sulagna Saitta; Donna McDonald-McGinn; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2004-04-30       Impact factor: 2.802

4.  Identification of deleterious mutations within three human genomes.

Authors:  Sung Chun; Justin C Fay
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

5.  Infantile myofibromatosis: two families supporting autosomal dominant inheritance.

Authors:  Annika Smith; David Orchard
Journal:  Australas J Dermatol       Date:  2011-03-01       Impact factor: 2.875

6.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

7.  Infantile myofibromatosis. Evidence for an autosomal-dominant disorder.

Authors:  T A Jennings; P H Duray; F S Collins; J Sabetta; F M Enzinger
Journal:  Am J Surg Pathol       Date:  1984-07       Impact factor: 6.394

8.  Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain.

Authors:  Charles Fouillade; Hugues Chabriat; Florence Riant; Manuèle Mine; Minh Arnoud; Laurent Magy; Marie Germaine Bousser; Elisabeth Tournier-Lasserve; Anne Joutel
Journal:  Hum Mutat       Date:  2008-03       Impact factor: 4.878

9.  Endocardial location of familial myofibromatosis revealed by cerebral embolization: cardiac counterpart of the frequent intravascular growth of the disease?

Authors:  Vincent Thomas de Montpréville; Leila Zemoura; Guy Vaksmann; Godeleine Lecourt-Tierny; Claude Planché; Elisabeth Dulmet
Journal:  Virchows Arch       Date:  2004-01-09       Impact factor: 4.064

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  51 in total

1.  Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome.

Authors:  Karen W Gripp; Katherine M Robbins; Nara L Sobreira; P Dane Witmer; Lynne M Bird; Kristiina Avela; Outi Makitie; Daniela Alves; Jacob S Hogue; Elaine H Zackai; Kimberly F Doheny; Deborah L Stabley; Katia Sol-Church
Journal:  Am J Med Genet A       Date:  2014-11-13       Impact factor: 2.802

Review 2.  The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.

Authors:  Tony Shen; Ariel Lee; Carol Shen; C Jimmy Lin
Journal:  Genet Res (Camb)       Date:  2015-09-14       Impact factor: 1.588

3.  A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.

Authors:  Jennifer J Johnston; Monica Y Sanchez-Contreras; Kim M Keppler-Noreuil; Julie Sapp; Molly Crenshaw; NiCole A Finch; Valerie Cormier-Daire; Rosa Rademakers; Virginia P Sybert; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2015-08-13       Impact factor: 11.025

4.  Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Authors:  Eliana Marisa Ramos; Miryam Carecchio; Roberta Lemos; Joana Ferreira; Andrea Legati; Renee Louise Sears; Sandy Chan Hsu; Celeste Panteghini; Luca Magistrelli; Ettore Salsano; Silvia Esposito; Franco Taroni; Anne-Claire Richard; Christine Tranchant; Mathieu Anheim; Xavier Ayrignac; Cyril Goizet; Marie Vidailhet; David Maltete; David Wallon; Thierry Frebourg; Lylyan Pimentel; Daniel H Geschwind; Olivier Vanakker; Douglas Galasko; Brent L Fogel; A Micheil Innes; Alison Ross; William B Dobyns; Diana Alcantara; Mark O'Driscoll; Didier Hannequin; Dominique Campion; João R Oliveira; Barbara Garavaglia; Giovanni Coppola; Gaël Nicolas
Journal:  Eur J Hum Genet       Date:  2018-06-28       Impact factor: 4.246

5.  A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.

Authors:  Cecilie Bredrup; Tomasz Stokowy; Julie McGaughran; Samuel Lee; Dipak Sapkota; Ileana Cristea; Linda Xu; Kåre Steinar Tveit; Gunnar Høvding; Vidar Martin Steen; Eyvind Rødahl; Ove Bruland; Gunnar Houge
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

Review 6.  Notch Signaling in Vascular Smooth Muscle Cells.

Authors:  J T Baeten; B Lilly
Journal:  Adv Pharmacol       Date:  2016-08-26

7.  Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.

Authors:  Cristina R Antonescu; Yun-Shao Sung; Lei Zhang; Narasimhan P Agaram; Christopher D Fletcher
Journal:  Am J Surg Pathol       Date:  2017-05       Impact factor: 6.394

Review 8.  What is new in pericytomatous, myoid, and myofibroblastic tumors?

Authors:  Ivy John; Karen J Fritchie
Journal:  Virchows Arch       Date:  2019-11-08       Impact factor: 4.064

Review 9.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 10.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.